Oral

[O1-1] SARS2-2

Sun. Nov 13, 2022 3:20 PM - 4:50 PM Room 1 (Conference Room 101)

Chair:
Kei Sato(Institute of Medical Science, University of Tokyo)
Yoshitaka Sato(Department of Virology, Nagoya University Graduate School of Medicine)

+Add all to schedule

3:20 PM - 3:35 PM

[O1-1-7] Establishment of a COVID-19 mouse model using novel human ACE2-expressing adenoviral vector

*Yusuke Matsumoto¹, Takahiro Sanada¹, Fumihiko Yasui¹, Michinori Kohara¹ (1. Tokyo Metropolitan Institute of Medical Science)

3:35 PM - 3:50 PM

[O1-1-8] Regulation of ACE2 by SARS-CoV-2 S protein

*Yosuke Maeda¹, Hiromi Terasawa¹, Mako Toyoda², Umiru Tokugawa¹, Takeo Kuwata², Kazuaki Monde¹, Shuzo Matsushita², Takamasa Ueno², Tomohiro Sawa¹ (1. Kumamoto University, Faculty of Life Sciences, 2. Kumamoto University, Joint Research Center for Human Retrovirus Infection)

3:50 PM - 4:05 PM

[O1-1-9] The impact of spike P681R and D950N mutations in SARS-CoV-2 Delta variant on viral characteristics

*Yuri Furusawa^1,2, Maki Kiso¹, Masaki Imai^1,2, Seiya Yamayoshi^1,2, Yoshihiro Kawaoka^1,2,3 (1. Division of Virology, Institute of Medical Science, University of Tokyo, 2. The Research Center for Global Viral Diseases, National Center for Global Health and Medicine Research Institute, 3. School of Veterinary Medicine, University of Wisconsin-Madison)

4:05 PM - 4:20 PM

[O1-1-10] Studies on SARS-CoV-2 replication in human nasal organoids

*Yukiko MURAMOTO¹, Kazuya SUZUKI², Masahiro NAKANO¹, Ai HIRABAYASHI¹, Masatoshi OHGUSHI², Saori HADA², Nobuko TANIYAMA², Chiho ONISHI¹, Mototsugu EIRAKU², Takeshi NODA¹ (1. Laboratory of Ultrastructural Virology, Institute for Life and Medical Sciences, Kyoto University, 2. Laboratory of Developmental Systems, , Institute for Life and Medical Sciences, Kyoto University)

4:20 PM - 4:35 PM

[O1-1-11] Development of an innovative research platform using human iPSC-derived cells for respiratory viruses including SARS-CoV-2

*Kouji Sakai¹, Shotaro Maehana², Ryota Mikawa³, Koji Tamai³, Misato Nishikawa⁴, Yurika Moteki², Yutaro Fukuzumi², Yasushi Ami¹, Kazuaki Takehara⁵, Hidero Kitasato², Knut Woltjen⁴, Yoshinori Yoshida⁴, Gotoh Gotoh³ (1. National Institute of Infectious Diseases, 2. Graduate School of Medical Sciences, Kitasato University, 3. Graduate School of Medicine, Kyoto University, 4. Center for iPS Cell Research and Application (CiRA), Kyoto University, 5. Tokyo University of Agriculture and Technology)

4:35 PM - 4:50 PM

[O1-1-12] Host RNA helicases regulate the SARS-CoV-2 infection and replication

*Yasuo Ariumi¹ (1. National Institute of Infectious Diseases)

Session information